相关实验视频

Updated: Jul 17, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

帕斯普拉纳玻璃切除术用于拖拉性糖尿病斑点,有或没有内部限制膜剥离

Abdelrahman Ahmed Ali Khattab¹, Mahmoud Mohammed Ahmed¹, Abdullah Hussein Hammed¹

¹Department of Ophthalmology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Medical hypothesis, discovery & innovation ophthalmology journal

|August 29, 2023

概括

帕斯普拉纳视切除术 (PPV) 有效地治疗了伸缩性糖尿病黄斑胀 (DME). 在这项研究中,额外的内部限制膜 (ILM) 剥离对视力或视网膜厚度没有显著的短期益处.

科学领域:

眼科医生眼科眼科
手术创新在外科创新.
糖尿病视网膜病变管理

背景情况:

运动性糖尿病黄斑 (DME) 是糖尿病患者视力丧失的重要原因.
在引性DME的帕斯普拉纳玻璃切除术 (PPV) 期间,内部限制膜 (ILM) 剥离的作用仍在争论中.
这项研究调查了ILM剥离与PPV结合用于治疗引性DME的疗效.

研究的目的:

评估帕斯普拉纳玻璃切除术 (PPV) 在治疗伸缩性糖尿病黄斑胀 (DME) 的有效性.
为了确定额外的内部限制膜 (ILM) 剥离是否提供功能或解剖方面的优势.
探索血糖控制和手术后视觉结果之间的相关性.

主要方法:

这是一项开放标签,前性,比较性研究,涉及50只患有引性DME的眼睛.
眼睛被分为两组:25人接受了没有ILM剥离的PPV (A组),25人接受了PPV和ILM剥离 (B组).
最好校正的距离视敏度 (BCDVA) 和中央黄斑厚度 (CMT) 在术后1,3个月和6个月被评估.

主要成果:

这两组在6个月后都显示出BCDVA的显著改善和CMT的减少 (P < 0.001).
在任何随访点 (P > 0.05) 中,在ILM剥离和不剥离组之间没有观察到BCDVA或CMT变化的统计学上显著差异.
在手术前HbA1c水平和BCDVA改善之间发现了显著的负相关性 (r = -0.82;P < 0.001).

结论:

帕斯平面视切除术 (PPV) 是一种有效的手术治疗拖拉性糖尿病黄斑 (DME) 的方法.
内部限制膜 (ILM) 剥离似乎不会在短期内提供显著的额外功能或解剖益处.
长期的血糖控制对于糖尿病患者的玻璃切除术后视力恢复至关重要,因此需要进一步调查.

关键词:

在糖尿病中,糖尿病是血糖性糖尿病.edemema edem 胀胀胀在胀胀糖基化血红蛋白A 是一个.内部限制膜的内部限制膜.黄斑 (macular) 是一个斑点.斑点水斑点水是什么?光学连贯性断层扫描技术视力敏度视力敏度视力敏度视力敏度玻璃切除术 (vitrectomy) 是一种切除器官的方法.

更多相关视频

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

A Step by Step Protocol for Subretinal Surgery in Rabbits

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...